Search





Search





Markets
/
Stocks
/
nasdaq-odtx
/

Odyssey Therapeutics Ord Shs (Proposed)

ODTX

Add to Watchlist

16.420USD

-1.580-8.78%

Close 05/08, 16:00（ET）Quotes delayed by 15 min

738.81MMarket Cap

LossP/E TTM



Odyssey Therapeutics Ord Shs (Proposed)

16.420

-1.580-8.78%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of Odyssey Therapeutics Ord Shs (Proposed) here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q3

Total equity

Cash, cash equivalents and short-term investments

--154.90K

- Cash and cash equivalents

--39.44K

-Short-term investments

--115.47K

Prepaid expenses

--4.93K

Total current assets

--159.83K

Non-current assets

Net Fixed Assets

--41.27K

-Fixed Assets

--51.67K

-Accumulated depreciation

--10.41K

Goodwill and other intangible assets

--14.95K

Other non-current assets

--5.48K

Total non-current assets

--61.70K

Total assets

--221.53K

Liabilities

Current liabilities

Accrued expenses

--10.96K

Deferred liabilities

--4.19K

Other current liabilities

--4.19K

Total current liabilities

--25.11K

Non-current liabilities

Long-term debt and lease liabilities

--27.64K

-Long-term lease liabilities

--27.64K

Other non-current liabilities

--9.84K

Total non-current liabilities

--37.48K

Total liabilities

--62.59K

Shareholders' equity

Common equity

--33.59K

Preferred equity

--508.21K

Retained earnings

---382.66K

Capital reserves

--33.59K

Gains losses not affecting retained earnings

---202.00

Total equity

--158.95K

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

